These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19724920)

  • 21. Antiproliferative activity of NQ304, a synthetic 1,4-naphthoquinone, is mediated via the suppressions of the PI3K/Akt and ERK1/2 signaling pathways in PDGF-BB-stimulated vascular smooth muscle cells.
    Kim TJ; Yun YP
    Vascul Pharmacol; 2007 Jan; 46(1):43-51. PubMed ID: 16875883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. YC-1-inhibited proliferation of rat mesangial cells through suppression of cyclin D1-independent of cGMP pathway and partially reversed by p38 MAPK inhibitor.
    Chiang WC; Teng CM; Lin SL; Chen YM; Tsai TJ; Hsieh BS
    Eur J Pharmacol; 2005 Jul; 517(1-2):1-10. PubMed ID: 15950964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expression.
    Kim DI; Lee SJ; Lee SB; Park K; Kim WJ; Moon SK
    Carcinogenesis; 2008 Sep; 29(9):1701-9. PubMed ID: 18296682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sphinganine causes early activation of JNK and p38 MAPK and inhibition of AKT activation in HT-29 human colon cancer cells.
    Ahn EH; Schroeder JJ
    Anticancer Res; 2006; 26(1A):121-7. PubMed ID: 16475687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest.
    Chan QK; Lam HM; Ng CF; Lee AY; Chan ES; Ng HK; Ho SM; Lau KM
    Cell Death Differ; 2010 Sep; 17(9):1511-23. PubMed ID: 20203690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of the p38 MAPK/Akt/ERK1/2 signal pathways is required for the protein stabilization of CDC6 and cyclin D1 in low-dose arsenite-induced cell proliferation.
    Liu Y; Hock JM; Sullivan C; Fang G; Cox AJ; Davis KT; Davis BH; Li X
    J Cell Biochem; 2010 Dec; 111(6):1546-55. PubMed ID: 20862710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NO-donating aspirin inhibits the growth of leukemic Jurkat cells and modulates beta-catenin expression.
    Nath N; Labaze G; Rigas B; Kashfi K
    Biochem Biophys Res Commun; 2005 Jan; 326(1):93-9. PubMed ID: 15567157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Benzo (a) pyrene-induced human embryo lung cell cycle alterations through positive regulation of mitogen-activated protein kinase signal pathways].
    DU HJ; Tang N; Liu BC; Shi XL; Huang CS; Gao A; Shen FH; Ye M; You BR
    Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Jul; 41(4):277-80. PubMed ID: 17959047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro metabolism of nitric oxide-donating aspirin: the effect of positional isomerism.
    Gao J; Kashfi K; Rigas B
    J Pharmacol Exp Ther; 2005 Mar; 312(3):989-97. PubMed ID: 15528452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model.
    Chattopadhyay M; Kodela R; Olson KR; Kashfi K
    Biochem Biophys Res Commun; 2012 Mar; 419(3):523-8. PubMed ID: 22366248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tetraarsenic hexoxide induces G2/M arrest, apoptosis, and autophagy via PI3K/Akt suppression and p38 MAPK activation in SW620 human colon cancer cells.
    Nagappan A; Lee WS; Yun JW; Lu JN; Chang SH; Jeong JH; Kim GS; Jung JM; Hong SC
    PLoS One; 2017; 12(3):e0174591. PubMed ID: 28355296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nitric oxide-donating aspirin inhibits the growth of pancreatic cancer cells through redox-dependent signaling.
    Zhou H; Huang L; Sun Y; Rigas B
    Cancer Lett; 2009 Jan; 273(2):292-9. PubMed ID: 18805632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resveratrol inhibits proliferation of human epidermoid carcinoma A431 cells by modulating MEK1 and AP-1 signalling pathways.
    Kim AL; Zhu Y; Zhu H; Han L; Kopelovich L; Bickers DR; Athar M
    Exp Dermatol; 2006 Jul; 15(7):538-46. PubMed ID: 16761963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinoic acid inhibits induction of c-Jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo.
    Fisher GJ; Talwar HS; Lin J; Lin P; McPhillips F; Wang Z; Li X; Wan Y; Kang S; Voorhees JJ
    J Clin Invest; 1998 Mar; 101(6):1432-40. PubMed ID: 9502786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Grape seed extract upregulates p21 (Cip1) through redox-mediated activation of ERK1/2 and posttranscriptional regulation leading to cell cycle arrest in colon carcinoma HT29 cells.
    Kaur M; Tyagi A; Singh RP; Sclafani RA; Agarwal R; Agarwal C
    Mol Carcinog; 2011 Jul; 50(7):553-62. PubMed ID: 21268136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MAPK/AP-1 signal pathway in tobacco smoke-induced cell proliferation and squamous metaplasia in the lungs of rats.
    Zhong CY; Zhou YM; Douglas GC; Witschi H; Pinkerton KE
    Carcinogenesis; 2005 Dec; 26(12):2187-95. PubMed ID: 16051644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of c-Jun N-terminal kinase (JNK) by widely used specific p38 MAPK inhibitors SB202190 and SB203580: a MLK-3-MKK7-dependent mechanism.
    Muniyappa H; Das KC
    Cell Signal; 2008 Apr; 20(4):675-83. PubMed ID: 18222647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peracetylated (-)-epigallocatechin-3-gallate (AcEGCG) potently prevents skin carcinogenesis by suppressing the PKD1-dependent signaling pathway in CD34+ skin stem cells and skin tumors.
    Chiou YS; Sang S; Cheng KH; Ho CT; Wang YJ; Pan MH
    Carcinogenesis; 2013 Jun; 34(6):1315-22. PubMed ID: 23385063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of protein kinase C modulation by PEP005, a novel ingenol angelate, on mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling in cancer cells.
    Serova M; Ghoul A; Benhadji KA; Faivre S; Le Tourneau C; Cvitkovic E; Lokiec F; Lord J; Ogbourne SM; Calvo F; Raymond E
    Mol Cancer Ther; 2008 Apr; 7(4):915-22. PubMed ID: 18413805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1.
    Bhowmik T; Gomes A
    Chem Biol Interact; 2017 Apr; 268():119-128. PubMed ID: 28322778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.